Università degli studi di Pavia
Contenuto della pagina
Guaman publications
Guamán-Ortiz Paper List:
1. Guamán-Ortiz L.M., Ramírez-Orellana M.I., Ratovitski E.A. “Natural compounds as modulators of non-apoptotic cell death in cancer cells”. Curret Genomics. 2017; 17. Doi: 10.2174/1389202917666160803150639.
2. Ferraroni M., Bazzicalupi C., Papi F., Fiorillo G., Guamán-Ortiz L. M., Scovassi A. I., Lombardi P., Gratteri P. “Solution and solid state analysis of binding of 13-substituted berberine analogues to human telomeric G-quadruplex”. Chemistry – An Asian Journal. 2016; 11: 1107 – 1115.
3. Guamán-Ortiz L.M., Croce A.L., Aredia F., Sapienza S., Fiorillo G., Syeda T.M., Buzzetti F., Lombardi P., Scovassi A.I. “Effect of new berberine derivatives on colon cancer cells”. Acta Biochim Biophys Sin. 2015; 47: 824 – 833.
4. Guamán-Ortiz L.M., Lombardi P., Tillhon M., Scovassi A.I. "Berberine, an epiphany against cancer". Molecules. 2014; 19: 12349 – 12367.
5. Guamán-Ortiz L.M., Tillhon M., Parks M., Dutto I., Prosperi E., Savio M., Arcamone A.G., Buzzetti F., Lombardi P., Scovassi A.I. "Multiple effects of berberine derivatives on colon cancer cells". BioMed Research International. 2014; 2014: 924585.
6. Scovassi A.I., Guamán-Ortiz L.M. “Traditional Medicine: An Ancient Remedy Rediscovered”. Biochem Pharmacol. 2013; 2: 110.
7. Aredia F., Giansanti V., Mazzini G., Savio M., Guamán-Ortiz L.M., Jaadane I., Zaffaroni N., Forlino A., Torriglia A., Scovassi A.I. “Multiple effects of the Na+/H+ antiporter inhibitor HMA on cancer cells”. Apoptosis, 2013, 18: 1586 – 1598.
8. Tillhon M., Guamán-Ortiz L. M., Lombardi P., Scovassi A. I. “Berberine: New perspectives for old remedies”. Biochemical Pharmacology. 2012, 84: 1260 – 1267.
9. Aredia F., Guamán-Ortiz L. M., Giansanti V., Scovassi A. I. “Autophagy and cancer”. Cells, 2012, 1: 520 – 534.
10. Guamán-Ortiz L. M. “Chronicles of a silent death: Apoptosis”. Research in Cell Biology, 2012, 1: 1 – 7.
11. Guamán-Ortiz L. M., Giansanti V., Dona F., Scovassi A. I. “Pharmacological effects of PARP inhibitors on cancer and other diseases”. Current Enzyme Inhibition. 2011, 7: 244 – 258.
1. Guamán-Ortiz L.M., Ramírez-Orellana M.I., Ratovitski E.A. “Natural compounds as modulators of non-apoptotic cell death in cancer cells”. Curret Genomics. 2017; 17. Doi: 10.2174/1389202917666160803150639.
2. Ferraroni M., Bazzicalupi C., Papi F., Fiorillo G., Guamán-Ortiz L. M., Scovassi A. I., Lombardi P., Gratteri P. “Solution and solid state analysis of binding of 13-substituted berberine analogues to human telomeric G-quadruplex”. Chemistry – An Asian Journal. 2016; 11: 1107 – 1115.
3. Guamán-Ortiz L.M., Croce A.L., Aredia F., Sapienza S., Fiorillo G., Syeda T.M., Buzzetti F., Lombardi P., Scovassi A.I. “Effect of new berberine derivatives on colon cancer cells”. Acta Biochim Biophys Sin. 2015; 47: 824 – 833.
4. Guamán-Ortiz L.M., Lombardi P., Tillhon M., Scovassi A.I. "Berberine, an epiphany against cancer". Molecules. 2014; 19: 12349 – 12367.
5. Guamán-Ortiz L.M., Tillhon M., Parks M., Dutto I., Prosperi E., Savio M., Arcamone A.G., Buzzetti F., Lombardi P., Scovassi A.I. "Multiple effects of berberine derivatives on colon cancer cells". BioMed Research International. 2014; 2014: 924585.
6. Scovassi A.I., Guamán-Ortiz L.M. “Traditional Medicine: An Ancient Remedy Rediscovered”. Biochem Pharmacol. 2013; 2: 110.
7. Aredia F., Giansanti V., Mazzini G., Savio M., Guamán-Ortiz L.M., Jaadane I., Zaffaroni N., Forlino A., Torriglia A., Scovassi A.I. “Multiple effects of the Na+/H+ antiporter inhibitor HMA on cancer cells”. Apoptosis, 2013, 18: 1586 – 1598.
8. Tillhon M., Guamán-Ortiz L. M., Lombardi P., Scovassi A. I. “Berberine: New perspectives for old remedies”. Biochemical Pharmacology. 2012, 84: 1260 – 1267.
9. Aredia F., Guamán-Ortiz L. M., Giansanti V., Scovassi A. I. “Autophagy and cancer”. Cells, 2012, 1: 520 – 534.
10. Guamán-Ortiz L. M. “Chronicles of a silent death: Apoptosis”. Research in Cell Biology, 2012, 1: 1 – 7.
11. Guamán-Ortiz L. M., Giansanti V., Dona F., Scovassi A. I. “Pharmacological effects of PARP inhibitors on cancer and other diseases”. Current Enzyme Inhibition. 2011, 7: 244 – 258.
